Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 2 |
2014 | 1 |
2015 | 2 |
2016 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Development of therapeutic combinations targeting major cancer signaling pathways.
J Clin Oncol. 2013 Apr 20;31(12):1592-605. doi: 10.1200/JCO.2011.37.6418. Epub 2013 Mar 18.
J Clin Oncol. 2013.
PMID: 23509311
Review.
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.
Barone G, Anderson J, Pearson AD, Petrie K, Chesler L.
Barone G, et al.
Clin Cancer Res. 2013 Nov 1;19(21):5814-21. doi: 10.1158/1078-0432.CCR-13-0680. Epub 2013 Aug 21.
Clin Cancer Res. 2013.
PMID: 23965898
Free PMC article.
Review.
Item in Clipboard
Long-term analysis of children with metastatic neuroblastoma treated in the ENSG5 randomised clinical trial.
Moreno L, Vaidya SJ, Schrey D, Pinkerton CR, Lewis IJ, Kearns PR, Machin D, Pearson ADJ; European Neuroblastoma Study Group and the Children's Cancer and Leukaemia Group (CCLG) (formerly UKCCSG).
Moreno L, et al.
Pediatr Blood Cancer. 2019 Apr;66(4):e27565. doi: 10.1002/pbc.27565. Epub 2018 Dec 5.
Pediatr Blood Cancer. 2019.
PMID: 30516328
Clinical Trial.
Item in Clipboard
Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma.
Smith JR, Moreno L, Heaton SP, Chesler L, Pearson AD, Garrett MD.
Smith JR, et al.
Mol Oncol. 2016 Apr;10(4):538-52. doi: 10.1016/j.molonc.2015.11.005. Epub 2015 Nov 19.
Mol Oncol. 2016.
PMID: 26686971
Free PMC article.
Clinical Trial.
Item in Clipboard
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG.
Vo KT, et al.
J Clin Oncol. 2014 Oct 1;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. Epub 2014 Aug 25.
J Clin Oncol. 2014.
PMID: 25154816
Free PMC article.
Item in Clipboard
Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.
Rafii S, Roda D, Geuna E, Jimenez B, Rihawi K, Capelan M, Yap TA, Molife LR, Kaye SB, de Bono JS, Banerji U.
Rafii S, et al.
Clin Cancer Res. 2015 Apr 15;21(8):1869-76. doi: 10.1158/1078-0432.CCR-14-2424. Epub 2015 Feb 3.
Clin Cancer Res. 2015.
PMID: 25649020
Free PMC article.
Item in Clipboard
Cite
Cite